• Skip to primary navigation
  • Skip to main content

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
      • SAGES Robotics Residents and Fellows Courses
      • MIS Fellows Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search the SAGES Site
    • Guidelines Search
    • Video Search
    • Search Images
    • Search Abstracts
  • OWLS/FLS
  • Login
You are here: Home / TAVACs / GI Genius

GI Genius

November 24, 2021 by Nova Lee Szoka

Author(s): Justin Williams,  Nova Szoka, MD, FACS, FASMBS

Medtronic received FDA approval for the GI Genius in April 2021.

The GI Genius is an artificial intelligence system used to aid in the detection of polyps and other precancerous lesions during routine colorectal screening. During screening colonoscopies, the GI Genius generates on-screen markers as well as short, low volume sounds to signal to clinicians that a suspected lesion has been detected and requires closer inspection and investigation.

The GI Genius consists of both hardware and software components that are compatible with many FDA-cleared white-light endoscopy devices. This allows endoscopists to incorporate artificial intelligence into their procedures with minimal effort.

The safety and efficacy of the GI Genius was assessed by the FDA through a multicenter, prospective, randomized, and controlled study in Italy. In this study, white-light endoscopy with the assistance of GI Genius, was able to identify lab-confirmed adenomas and carcinomas in 55.1% of patients, compared to 42.0% in the white-light endoscopy control group, with an observed difference of 13%. Use of the GI Genius led to an increased number of biopsies performed, but no adverse events were reported as a result.

The FDA determined that the GI Genius is effective in assisting endoscopists in identifying possible lesions, allowing the clinician to further investigate the potential lesion. The GI Genius should not be used as a replacement for clinical decision-making, as further investigation is required by the endoscopist.

Indications for use:

  • Adult patients undergoing screening and surveillance endoscopic mucosal evaluations

Contraindications:

  • Patients who do not meet the criteria to undergo standard white-light endoscopy

References:

Hassan C, Wallace MB, Sharma P, Maselli R, Craviotto V, Spadaccini M, Repici A. New artificial intelligence system: first validation study versus experienced endoscopists for colorectal polyp detection. Gut. 2020 April;69(5):799-800. http://dx.doi.org/10.1136/gutjnl-2019-319914.

198
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2025 Society of American Gastrointestinal and Endoscopic Surgeons